Format

Send to

Choose Destination
Curr Opin Microbiol. 2013 Oct;16(5):538-48. doi: 10.1016/j.mib.2013.06.012. Epub 2013 Jul 26.

Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics.

Author information

1
Infectious Disease Research, Merck Research Laboratories, Kenilworth, NJ 07033, USA. Electronic address: terry_roemer@merck.com.

Abstract

Combination agents provide an important orthogonal approach to treat infectious diseases, particularly those caused by drug resistant pathogens. Indeed, applying a biologically 'rational' and systems-level paradigm to discover potent, selective, and synergistic agents would augment current (and arguably overly relied upon) empirical and serendipitous approaches to such discovery efforts. Here, we review the cellular mechanisms of β-lactam drug resistance and tolerance achieved amongst methicillin-resistant Staphylococcus aureus (MRSA) as well as their molecular targets and strategies to identify cognate inhibitors as potential combination agents to restore β-lactam efficacy against MRSA.

PMID:
23895826
DOI:
10.1016/j.mib.2013.06.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center